Go Back
DNA Capital
DNA Capital, a Venture Fund based in São Paulo, Brazil, was founded in 2013. Specializing in multi-stage investments in the healthcare sector, their fund stages include Seed, Series A, Series B, Series C, and Series D. With a focus on Healthcare, Medical Device, BioTech, and Life Science industries, DNA Capital has invested in 28 companies and celebrated 2 successful exits. The fund is led by Partner Chris Hill, who can be reached at chill@dnacapital.com. Portfolio companies under DNA Capital's wing include Nice Healthcare and Spotlight Therapeutics. For more information, visit their website at www.dnacapital.com.
About
About
About
Bio
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
Location
São Paulo, Brazil
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Chris Hill
Bio
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
Location
São Paulo, Brazil
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Chris Hill
Fund
Fund
Fund
Fund Focus
Healthcare, Medical Device, BioTech, Life Science
Number of investments
28
Number of exits
2
Fund Type
Venture Fund
Portfolio Companies
Nice Healthcare, Spotlight Therapeutics
DNA Capital
DNA Capital, a Venture Fund based in São Paulo, Brazil, was founded in 2013. Specializing in multi-stage investments in the healthcare sector, their fund stages include Seed, Series A, Series B, Series C, and Series D. With a focus on Healthcare, Medical Device, BioTech, and Life Science industries, DNA Capital has invested in 28 companies and celebrated 2 successful exits. The fund is led by Partner Chris Hill, who can be reached at chill@dnacapital.com. Portfolio companies under DNA Capital's wing include Nice Healthcare and Spotlight Therapeutics. For more information, visit their website at www.dnacapital.com.
About
Bio
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
Location
São Paulo, Brazil
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Chris Hill
Fund
Fund Focus
Healthcare, Medical Device, BioTech, Life Science
Number of investments
28
Number of exits
2
Fund Type
Venture Fund
Portfolio Companies
Nice Healthcare, Spotlight Therapeutics